U-Blot® Research Grade Abrezekimab

U-Blot® Research Grade Abrezekimab
U-Blot® Research Grade Abrezekimab
$9,999.00
Size:50ug
SKU: WA1013-50

Catalog No.: WA1013

Specification: 50ug/100ug

Stock: In stock

Product details, specifications, documents, and related products are available from the catalog record. Learn more

10.19产品详情通用banner:Join us at JSI 2026 to explore the future of immunology! See you in Osaka!data:11.20;local:xxxxxxxxxxxxxx
Learn more

Product information

Product details, specifications, documents, and related products are available from the catalog record.

Product Overview

Catalog No.
WA1013
SKU
WA1013-50
Category
Biosimilar Antibodies
Product Type
Other
Size
50ug/100ug
Stock Status
In stock
Available Stock
999
Minimum Order Quantity
1

Storage & Compliance

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Research Use Only
Yes

Additional Specifications

PackSize
50ug/100ug
Target
IL13
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host Species
Humanized
Isotype
Fab-G1-kappa
Conjugate/Modification
--
Recommended Dilution Ratio
--
Composition
0.01M PBS, pH 7.4.
Purification Process
Protein A/G purified from cell culture supernatant.
Purity
>95% as determined by SDS-PAGE.
storageCondition
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clonality
Monoclonal
Clone Number
--
Immunogen
Mammalian Cells
Alias
IL13, NC30, Interleukin-13, IL-13
Species
--
Gene ID-1
P35225
Uniprot
--
Background
Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis).<br>
Tissue Expression
--
Signaling_pathway
--
Research Areas
--

Tech Support

ucallm

01

Documents

Datasheet, COA, SDS, and protocol files can be requested from technical support.

02

Storage & Handling

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
06

Contact Support

Emailinfo@mail.ucallm.com

Phone+(1)-866-986-9598

WeChat / IMUcallm-Tech

HoursMonday-Friday 09:00-18:00 CST

Request Technical Support
Keywords:Biosimilar Antibodies